核酸検査市場レポート：2030年までの動向、予測、競合分析

核酸検査の動向と予測

世界の核酸検査市場は、2024年から2030年までのCAGRが11.2%で、2030年までに推定67億米ドルに達すると予測されます。この市場の主な促進要因は、正確で迅速な診断検査に対するニーズの高まり、血液バンクや輸血センターからの核酸検査キットに対するニーズの高まり、がん、遺伝性疾患、感染症の罹患率の上昇です。世界の核酸検査市場の将来は、病院・診療所、病理検査室、学術・研究機関市場のビジネスチャンスによって有望視されています。

核酸検査市場の洞察

Lucintelの予測では、感染症は、ウイルス量を決定するのに役立つ遺伝子型およびサブタイプ同定のための核酸検査キットがかなり使用されているため、最大のセグメントであり続けると思われます。

北米は、人口の間で感染症の流行が増加していることと、核酸検査研究開発に対する政府の強力な支援の存在により、予測期間中に最も高い成長が見込まれています。

本レポートは、以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.市場セグメントのうち、最も有望かつ高成長するのは何か？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の核酸検査市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の核酸検査市場動向（2018-2023）と予測（2024-2030）
• 製品タイプ別の世界の核酸検査市場
  • ポリメラーゼ連鎖反応
  • リガーゼ連鎖反応
  • 転写媒介増幅
  • 全ゲノム配列決定
  • その他
• 適応症別の世界の核酸検査市場
  • 感染症
  • がん
  • 法医学検査
  • 個別化医療
  • その他
• 最終用途別の世界の核酸検査市場
  • 病院とクリニック
  • 病理研究所
  • 学術・研究組織
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の核酸検査市場
• 北米の核酸検査市場
• 欧州の核酸検査市場
• アジア太平洋の核酸検査市場
• その他地域核酸検査市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品タイプ別の世界の核酸検査市場の成長機会
  • 適応症別の世界の核酸検査市場の成長機会
  • 最終用途別の世界の核酸検査市場の成長機会
  • 地域別の世界の核酸検査市場の成長機会
• 世界の核酸検査市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の核酸検査市場の能力拡大
  • 世界の核酸検査市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• F. Hoffmann-La Roche
• Becton and Dickinson
• Danaher
• Abbott Laboratories
• Illumina
• Siemens Healthineers
• bioMerieux

Nucleic Acid Testing Trends and Forecast

The future of the global nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets. The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030 with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.

A more than 150-page report is developed to help in your business decisions.

Nucleic Acid Testing by Segment

The study includes a forecast for the global nucleic acid testing by product type, indication, end use, and region.

Nucleic Acid Testing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Polymerase Chain Reaction
• Ligase Chain Reaction
• Transcription-Mediated Amplification
• Whole Genome Sequencing
• Others

Nucleic Acid Testing Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Infectious Disease
• Cancer
• Forensic Testing
• Personalized Medicine
• Others

Nucleic Acid Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Pathology Laboratories
• Academic & Research Organization
• Others

Nucleic Acid Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Nucleic Acid Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nucleic acid testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nucleic acid testing companies profiled in this report include-

• F. Hoffmann-La Roche
• Becton and Dickinson
• Danaher
• Abbott Laboratories
• Illumina
• Siemens Healthineers
• bioMerieux

Nucleic Acid Testing Market Insights

Lucintel forecasts that infectious disease will remain the largest segment due to considerable use of nucleic acid testing kit for genotype and subtype identification that aids in determining viral load.

North America is expected to witness highest growth over the forecast period due to increasing prevalence of infectious diseases among population and presence of strong government support for nucleic acid testing research and development in the region.

Features of the Global Nucleic Acid Testing Market

Market Size Estimates: Nucleic acid testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nucleic acid testing market size by product type, indication, end use, and region in terms of value ($B).

Regional Analysis: Nucleic acid testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, indications, end uses, and regions for the nucleic acid testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nucleic acid testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the nucleic acid testing market size?

Answer: The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030.

Q.2 What is the growth forecast for nucleic acid testing market?

Answer: The global nucleic acid testing market is expected to grow with a CAGR of 11.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the nucleic acid testing market?

Answer: The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.

Q4. What are the major segments for nucleic acid testing market?

Answer: The future of the nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets.

Q5. Who are the key nucleic acid testing market companies?

Answer: Some of the key nucleic acid testing companies are as follows:

• F. Hoffmann-La Roche
• Becton and Dickinson
• Danaher
• Abbott Laboratories
• Illumina
• Siemens Healthineers
• bioMerieux

Q6. Which nucleic acid testing market segment will be the largest in future?

Answer: Lucintel forecasts that infectious disease will remain the largest segment due to considerable use of nucleic acid testing kit for genotype and subtype identification that aids in determining viral load.

Q7. In nucleic acid testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of infectious diseases among population and presence of strong government support for nucleic acid testing research and development in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the nucleic acid testing market by product type (polymerase chain reaction, ligase chain reaction, transcription-mediated amplification, whole genome sequencing, and others), indication (infectious disease, cancer, forensic testing, personalized medicine, and others), end use (hospitals & clinics, pathology laboratories, academic & research organization, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nucleic Acid Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Nucleic Acid Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Nucleic Acid Testing Market by Product Type
  • 3.3.1: Polymerase Chain Reaction
  • 3.3.2: Ligase Chain Reaction
  • 3.3.3: Transcription-mediated Amplification
  • 3.3.4: Whole Genome Sequencing
  • 3.3.5: Others
• 3.4: Global Nucleic Acid Testing Market by Indication
  • 3.4.1: Infectious Disease
  • 3.4.2: Cancer
  • 3.4.3: Forensic Testing
  • 3.4.4: Personalized Medicine
  • 3.4.5: Others
• 3.5: Global Nucleic Acid Testing Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Pathology Laboratories
  • 3.5.3: Academic & Research Organization
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Nucleic Acid Testing Market by Region
• 4.2: North American Nucleic Acid Testing Market
  • 4.2.1: North American Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
  • 4.2.2: North American Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
• 4.3: European Nucleic Acid Testing Market
  • 4.3.1: European Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
  • 4.3.2: European Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
• 4.4: APAC Nucleic Acid Testing Market
  • 4.4.1: APAC Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
  • 4.4.2: APAC Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
• 4.5: ROW Nucleic Acid Testing Market
  • 4.5.1: ROW Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
  • 4.5.2: ROW Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Nucleic Acid Testing Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Nucleic Acid Testing Market by Indication
  • 6.1.3: Growth Opportunities for the Global Nucleic Acid Testing Market by End Use
  • 6.1.4: Growth Opportunities for the Global Nucleic Acid Testing Market by Region
• 6.2: Emerging Trends in the Global Nucleic Acid Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Nucleic Acid Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic Acid Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F. Hoffmann-La Roche
• 7.2: Becton and Dickinson
• 7.3: Danaher
• 7.4: Abbott Laboratories
• 7.5: Illumina
• 7.6: Siemens Healthineers
• 7.7: bioMerieux